NCT00026312
Clinical Trial Information
Trial Number: NCT00026312 (ClinicalTrials.gov)
Disease Type:
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
Trial Title:
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Study ID:
ANBL0032
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®